Insilico Medicine introduced Nach01, a multimodal foundation AI model on AWS Marketplace designed to enhance generative chemistry capabilities in drug discovery. Separately, Northwestern University researchers developed a generative AI model, TWAVE, that predicts gene sets implicated in complex diseases. MIT and Recursion Pharmaceuticals released Boltz-2, an advanced open-source AI model improving small-molecule binding affinity predictions, collectively pushing computational horizons in biotech innovation.